127 related articles for article (PubMed ID: 10095106)
1. TRAG-3, a novel gene, isolated from a taxol-resistant ovarian carcinoma cell line.
Duan Z; Feller AJ; Toh HC; Makastorsis T; Seiden MV
Gene; 1999 Mar; 229(1-2):75-81. PubMed ID: 10095106
[TBL] [Abstract][Full Text] [Related]
2. MM-TRAG (MGC4175), a novel intracellular mitochondrial protein, is associated with the taxol- and doxorubicin-resistant phenotype in human cancer cell lines.
Duan Z; Brakora KA; Seiden MV
Gene; 2004 Sep; 340(1):53-9. PubMed ID: 15556294
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MAGE/GAGE genes in paclitaxel/doxorubicin-resistant human cancer cell lines.
Duan Z; Duan Y; Lamendola DE; Yusuf RZ; Naeem R; Penson RT; Seiden MV
Clin Cancer Res; 2003 Jul; 9(7):2778-85. PubMed ID: 12855658
[TBL] [Abstract][Full Text] [Related]
4. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV
Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors.
Yao X; Hu JF; Li T; Yang Y; Sun Z; Ulaner GA; Vu TH; Hoffman AR
Cancer Genet Cytogenet; 2004 May; 151(1):1-13. PubMed ID: 15120907
[TBL] [Abstract][Full Text] [Related]
6. Taxol-resistance-associated gene-3 (TRAG-3/CSAG2) expression is predictive for clinical outcome in ovarian carcinoma patients.
Materna V; Surowiak P; Kaplenko I; Spaczyński M; Duan Z; Zabel M; Dietel M; Lage H
Virchows Arch; 2007 Feb; 450(2):187-94. PubMed ID: 17216190
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of differential gene expression between sensitive and resistant ovarian tumor cells by fluorescence differential display-PCR analysis.
Li L; Luan Y; Li X; Tang B; Zhang W; Li D; Zhao J; Wang G; Ding H; Reed E; Li QQ
Oncol Rep; 2005 May; 13(5):793-9. PubMed ID: 15809740
[TBL] [Abstract][Full Text] [Related]
8. TRAG-3, a novel cancer/testis antigen, is overexpressed in the majority of melanoma cell lines and malignant melanoma.
Feller AJ; Duan Z; Penson R; Toh HC; Seiden MV
Anticancer Res; 2000; 20(6B):4147-51. PubMed ID: 11205240
[TBL] [Abstract][Full Text] [Related]
9. Cancer/testis antigen CSAGE is concurrently expressed with MAGE in chondrosarcoma.
Lin C; Mak S; Meitner PA; Wolf JM; Bluman EM; Block JA; Terek RM
Gene; 2002 Feb; 285(1-2):269-78. PubMed ID: 12039054
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of the complementary DNA for the M(r) 85,000 protein overexpressed in adriamycin-resistant human tumor cells.
Sugimoto Y; Hamada H; Tsukahara S; Noguchi K; Yamaguchi K; Sato M; Tsuruo T
Cancer Res; 1993 Jun; 53(11):2538-43. PubMed ID: 8495417
[TBL] [Abstract][Full Text] [Related]
11. Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line.
Lamendola DE; Duan Z; Yusuf RZ; Seiden MV
Cancer Res; 2003 May; 63(9):2200-5. PubMed ID: 12727840
[TBL] [Abstract][Full Text] [Related]
12. [The selection of taxol resistance associated genes in ovarian cancer cell line by mRNA DD].
Cheng G; Tian F; Li Y
Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):541-3. PubMed ID: 11798816
[TBL] [Abstract][Full Text] [Related]
13. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
Duan Z; Lamendola DE; Duan Y; Yusuf RZ; Seiden MV
Cancer Chemother Pharmacol; 2005 Mar; 55(3):277-85. PubMed ID: 15565326
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous T-cell responses against peptides derived from the Taxol resistance-associated gene-3 (TRAG-3) protein in cancer patients.
Meier A; Reker S; Svane IM; Holten-Andersen L; Becker JC; Søndergaard I; Andersen MH; Thor Straten P
Cancer Immunol Immunother; 2005 Mar; 54(3):219-28. PubMed ID: 15580499
[TBL] [Abstract][Full Text] [Related]
15. [RNA interference silencing expression of survivin gene and reversing drug resistance of ovarian cancer cell line SKOV3/ADM].
Deng KX; Zhong L; Jiang MX; Wang PL; Chen Y
Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):836-9. PubMed ID: 16412331
[TBL] [Abstract][Full Text] [Related]
16. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer.
Ishibashi M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Fukumoto M; Miyazaki K
Clin Cancer Res; 2008 May; 14(10):3149-55. PubMed ID: 18483383
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
18. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
[TBL] [Abstract][Full Text] [Related]
19. Expression of the TRAG-3 gene in human esophageal cancer: the frequent synchronous expression of MAGE-3 gene.
Ohta M; Tanaka F; Sadanaga N; Yamaguchi H; Inoue H; Mori M
Oncol Rep; 2006 Jun; 15(6):1529-32. PubMed ID: 16685391
[TBL] [Abstract][Full Text] [Related]
20. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
Parekh H; Wiesen K; Simpkins H
Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
